22nd IMS Annual Meeting – Toronto

The International Myeloma Society (IMS) Annual Meeting is the defining global event in the myeloma calendar — bringing together leading clinicians, researchers, and healthcare professionals to share the latest insights across the myeloma care spectrum.

Now in its 22nd year, the meeting offers a valuable opportunity for HCPs working in myeloma to deepen their understanding of disease biology, explore new treatment strategies, and engage with cutting-edge research that informs clinical practice.

This year’s scientific programme includes:

• Thematic sessions focused on key areas in current myeloma care:
  • Precursor disease
  • Risk-adapted management
  • Immunotherapy
  • Relapse within 1–3 lines of treatment
• Talks and symposia led by key opinion leaders in the global myeloma community
• Keynote addresses from world-renowned experts
• Joint sessions with regulatory agencies and collaborative organisations
• Meet the Expert opportunities for in-depth discussions
• Oral abstract presentations covering basic biology, preclinical work, and clinical studies
• Poster sessions and discussions showcasing new data and innovations

This is a key opportunity for healthcare professionals involved in myeloma care to stay informed, connect with peers, and contribute to the future direction of research and treatment.